June 12, 2025
Trending Now
Home Region Europe (page 3)

Europe

Siemens Healthineers introduces new clinical field strength in MR imaging

Siemens Healthineers has achieved a CE approval for the 7 Tesla magnetic resonance (MR) scanner Magnetom Terra, making it the first-ever ultra-high-field MR scanner to be approved for clinical use. Siemens Healthineers, the global market and innovation leader in magnetic resonance imaging (MRI), is therefore breaking new ground in medical imaging once again and working alongside customers to establish a …

Read More

Vituro Health Expands Into Arkansas, Providing The Latest In Precision Prostate Cancer Care

Vituro Health and Arkansas Urology, LUGPA member and the largest urology practice in the state, partnered to offer patients in Arkansas and surrounding states the latest, most innovative technologies in prostate cancer treatment and precision disease management. In conjunction with Vituro Health, Arkansas Urology will offer patients advanced diagnostics, navigation services, and HIFU (High Intensity Focused Ultrasound) therapy. “Arkansas Urology …

Read More

bioMérieux Receives FDA Clearance for Expanded Pathogen Identification Capability on VITEK® MS

bioMérieux, a world leader in the field of in vitro diagnostics announced that VITEK® MS, its MALDI-TOF1 Mass Spectrometry System for rapid pathogen identification, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded identification of mycobacteria, Nocardia and moulds. This database includes more than 15,000 distinct strains to provide extremely high accuracy and, for …

Read More

Cardinal Health announced that it has completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1 billion. The acquisition was funded with a combination of $4.5 billion in new senior unsecured notes, existing cash and borrowings under our existing credit arrangements. “This business provides our customers with more product offerings and includes some well-established brands that fit naturally within our portfolio and are complementary to our current medical products business. We know these products and many of the employees well, and have seen that our team members share a common commitment to quality, customer service and the patients who we all ultimately serve,” said George Barrett, chairman and CEO of Cardinal Health. “We are extremely excited about welcoming our new colleagues from around the world to Cardinal Health.” The Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business encompasses 23 product categories across multiple market sites of care, including numerous industry-leading brands, such as Curity, Kendall, Dover, Argyle and Kangaroo – brands used in nearly every U.S. hospital. The company also previously announced that it expects the acquisition to be accretive to non-GAAP¹ diluted earnings per share from continuing operations by more than $0.21 per share in fiscal 2018, net of incremental annual financing-related interest expense, and includes up to $100 million of inventory step-up costs during the first few quarters following closing. As previously disclosed, the company still expects the acquisition to be accretive to non-GAAP diluted earnings per share by more than $0.55 per share in fiscal 2019, and increasingly accretive thereafter. By the end of fiscal 2020, the company assumes synergies will exceed $150 million. The Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business will become part of Cardinal Health’s Medical segment, which is led by Don Casey, the segment’s chief executive officer. Integration efforts are off to a successful start and it is expected that all integration work and transitions will be completed over the next 18 months. Goldman, Sachs & Co. and Perella Weinberg Partners LP served as Cardinal Health’s financial advisors on this transaction, and Skadden, Arps, Slate, Meagher & Flom LLP and Jones Day served as its legal advisors.

TTP plc announces that they have established a non-exclusive partnership to offer services to molecular diagnostic technology developers. The new offering will include comprehensive product development services that span instrumentation, consumables and reagents. The partnership is focused on supporting customers in the molecular diagnostic and wider life science space to rapidly transition ideas into commercially successful products. The services will …

Read More

Blue Earth Diagnostics Appoints M2i to Manufacture and Distribute Axumin™ in Ireland

Blue Earth Diagnostics announced that they have entered into an exclusive manufacturing and distribution agreement for the supply of Blue Earth Diagnostics’ PET imaging product Axumin™ (fluciclovine (18F)) in Ireland. M2i, through their Dublin PET manufacturing site, will bring Axumin to market in the Republic of Ireland and in Northern Ireland. Axumin is indicated in Europe for use in PET …

Read More

Envision Physician Services Acquires Anesthesia Group Practice Based in New London, Connecticut

Envision Healthcare Corporation announced that Envision Physician Services acquired Anesthesia Associates of New London, P.C., a Connecticut-based anesthesia physician group practice. Anesthesia Associates is the exclusive provider of anesthesia services at Lawrence and Memorial Hospital in New London, as well as three ambulatory surgery centers in the area. The practice has more than 25 clinical professionals, including 10 physicians. “As …

Read More

Zimmer Biomet Introduces X-Ray-Based Patient Specific Instrument System

Zimmer Biomet Holdings introduced its X-ray-based Patient Specific Instrument, X-PSI™ Knee System, which is the world’s first CE Marked surgical planning system that allows for patient specific implant positioning solely utilizing X-ray technology. X-PSI Knee System, for use with Zimmer Biomet’s flagship total knee brands, allows surgeons to use X-ray images to generate three-dimensional anatomic models. Zimmer Biomet’s Patient Specific …

Read More

Isala and Elekta Sign Long-term Partnership Agreement for Optimal Cancer Care

Isala and Elekta signed a 15-year partnership agreement to implement the latest developments in oncology and radiotherapy at Isala. Next to upgrading existing equipment the agreement also includes several Versa HD™ linear accelerators, a Leksell Gamma Knife® Icon™ radiosurgery system, MOSAIQ® workflow software and a managed services contract. Elekta and Isala today also announced the start of a long-term technology …

Read More

DOCAPOST and Tactio Announce Strategic Partnership to Accelerate the Development of eHealth in France

DOCAPOST, a subsidiary of Le Groupe La Poste, and Tactio Health Group, the world leader in mobile health systems, have teamed up to speed up the development of eHealth in France. This partnership is supported by DOCAPOST’s industrial capabilities in the health prevention and telehealth sectors in France. Tactio brings its genuine technological expertise and business savvy in mobile and …

Read More

Mobidiag Extends Distribution Agreement with PerkinElmer to Offer Amplidiag® Diagnostics Products

Mobidiag Ltd announced the expansion of its distribution agreement with PerkinElmer’s Wallac Oy subsidiary to include distribution of the Amplidiag® product line in Israel and several countries in Africa. The Amplidiag® product line, including in vitro diagnostic tests and compatible systems for the detection of gastrointestinal infections, is now distributed in Botswana, Ghana, Ivory Coast, Kenya, Mauritius, Morocco, Mozambique, Nigeria, …

Read More
1234Page 3 of 4

Recent Comments

    © Copyright 2016, All Rights Reserved Powered by WordPress | Designed by Bdaia